Dr Burlinson was appointed as a member in April 2003. He has a great
deal of experience in the development of new assays important to the COM's
recommended strategy for testing (for example the COMET and UDS assays).
He has been involved in collaborative work with other laboratories in
EU and wider. He is interested in communication of complex risk assessment
issues to the general public.
You
are here: 